Nanomagnets clean blood


Nanoparticles that never have to enter the body can capture harmful components in blood, scientists in Switzerland have shown.

Removing unwanted molecules from the blood is the most direct way to cure or prevent many illnesses. An example of this approach is dialysis where small molecules like urea are filtered out to treat patients with renal failure. As this separation method is size-selective, larger noxious molecules or cells cannot be efficiently eliminated from the blood in this way.

Nanoparticles with capturing agents attached to their surface can remove larger molecules from blood. However, the risks of nanoparticles inside the body are not yet completely understood. Inge Herrmann from Zurich University Hospital and her co-workers have developed a lab-scale device that connects the carotid artery with the jugular vein allowing outside-of-the-body treatment by tiny magnetic particles in a rodent model.

The group used their extracorporeal circuit to remove lead and the drug digoxin from the blood of rats. Target compounds in blood adhered to the nanoparticles as they collided within the circuit. The nanoparticles were then collected by magnetic separation with the toxin immobilised on the particle surface before blood could re-enter the body.

The nanoparticles were made from iron carbide. A carbon coating prevents the iron core from being oxidised and losing its magnetism. They were also spiked with platinum so they could be traced in an iron-rich environment – important for checking that none of the nanoparticles entered the rats.

Herrmann says that the limitations of using nanoparticles in this setting are their unknown health effects, and the major challenge is making sure they do not enter the blood stream. ‘By using ultra-strong magnetic nanoparticles we overcame limitations of commonly used weakly magnetic metal oxide beads.’

‘The significant advance of this work over previous research is that they used nanoparticles with a high magnetic moment,’ says Nguyen TK Thanh, an expert in the use of magnetic nanoparticles for clinical applications at University College London, UK. ‘This allowed them to be efficiently purified from the blood.’

‘It is a promising development,’ says Thanh. ‘However, for clinical application there are still challenges in developing a technology that can meet the needs of selective and high affinity binding for a variety of relevant toxins.’ The researchers in Zurich are now working on capturing other disease-causing substances like bacteria.


Related Content

Chemistry World podcast - September 2013

2 September 2013 Podcast | Monthly

news image

Emma Smith surveys the prospects for chemistry graduates and Polly Arnold looks at plugging the leaky pipeline of women in ch...

Zeolite–polymer composite adsorbs uremic toxins

19 February 2014 Research

news image

Nanofibre mesh that soaks up creatinine is an important step towards a portable blood purification system

Most Read

Antimicrobial resistance will kill 300 million by 2050 without action

16 December 2014 News and Analysis

news image

UK report says resistance will cost global economy $100 trillion

Cutting edge chemistry in 2014

10 December 2014 Research

news image

We take a look back at the year's most interesting chemical science stories

Most Commented

A bad business

19 December 2014 Critical Point

news image

Targets and assessments can boost productivity at universities – but only if they do not stifle creativity and alienate the...

Unusual 2D silica allotrope predicted

25 June 2014 Research

news image

Simulations say graphene-like silica would become thicker when stretched